Anti-BCL9 aptamer SELEX Service(Cat#: CTApt-1885)

Name: Anti-BCL9 aptamer SELEX Service
SKU: CTApt-1885
Rating: 5 (1 reviews)

This is an aptamer development services to screening aptamers binds to the BCL9 with an affinity of 1nM~1μM.

Certificate of Analysis Lookup

To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.

Lot Number

Specifications

Target Category	Protein
Target	BCL9
Alternative Names	BCL9 Transcription Coactivator; B-Cell CLL/Lymphoma 9 Protein; B-Cell Lymphoma 9 Protein; Protein Legless Homolog; B Cell CLL/Lymphoma 9; Bcl-9; BCL9, Transcription Coactivator; BCL9; LGS
Gene ID	607
UniProt ID	O00512
Target Overview	BCL9 is associated with B-cell acute lymphoblastic leukemia. It may be a target of translocation in B-cell malignancies with abnormalities of 1q21. Its function is unknown. The overexpression of BCL9 may be of pathogenic significance in B-cell malignancies.
Chemical Modification	N/A
Type	DNA
Length	20-80 nt
Affinity (Kd)	1nM~1μM
Binding Conditions/Buffer	PBS; buffer system with Serum; other